Mesdjian, E <br/><br/>
Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies.  [electronic resource] 

 -  Life sciences  1999 
 - 827-35 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0024-3205 
<br/><br/><label>Standard No.: </label>10.1016/s0024-3205(99)00004-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Bacterial Agents--metabolism<br/>Antibodies--pharmacology<br/>Anticonvulsants--metabolism<br/>Aryl Hydrocarbon Hydroxylases<br/>Biotransformation<br/>Carbamazepine--metabolism<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--immunology<br/>Dextromethorphan--metabolism<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Enzyme Induction--drug effects<br/>Enzyme Inhibitors--metabolism<br/>Epilepsy--drug therapy<br/>Hypnotics and Sedatives--metabolism<br/>In Vitro Techniques<br/>Male<br/>Microsomes, Liver--drug effects<br/>Nifedipine--metabolism<br/>Protein Isoforms--antagonists & inhibitors<br/>Rabbits